Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Consuelo Anzilotti

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Cellular & Molecular Immunology|June 20, 2017
Themis2: setting the threshold for B-cell selectionMukta Deobagkar-Lele, Consuelo Anzilotti, Richard J Cornall
Autoimmunity Reviews|June 23, 2009
Peptidylarginine deiminase 4 and citrullination in health and diseaseConsuelo Anzilotti, Federico Pratesi, Cristina Tommasi, et al.
Arthritis and Rheumatism|March 2, 2006
Deiminated Epstein-Barr virus nuclear antigen 1 is a target of anti-citrullinated protein antibodies in rheumatoid arthritisFederico Pratesi, Cristina Tommasi, Consuelo Anzilotti, et al.
Annals of the New York Academy of Sciences|July 15, 2005
A deiminated viral peptide to detect antibodies in rheumatoid arthritisGiuseppina Merlini, Consuelo Anzilotti, Daniele Chimenti, et al.
The Journal of Rheumatology|March 3, 2006
Antibodies to viral citrullinated peptide in rheumatoid arthritisConsuelo Anzilotti, Giuseppina Merlini, Federico Pratesi, et al.
Frontiers in Immunology|October 24, 2018
Immune Checkpoints as Therapeutic Targets in AutoimmunityChristopher Paluch, Ana Mafalda Santos, Consuelo Anzilotti, et al.
The Journal of Rheumatology|April 4, 2006
Prevalence and clinico-serological correlations of anti-alpha-enolase, anti-C1q, and anti-dsDNA antibodies in patients with systemic lupus erythematosusMarta Mosca, Daniele Chimenti, Federico Pratesi, et al.
Immunotherapy Advances|April 21, 2023
Combination CD200R/PD-1 blockade in a humanised mouse modelMartin Fellermeyer, Consuelo Anzilotti, Christopher Paluch, et al.
European Cytokine Network|December 4, 2010
Serum and urinary levels of IL-18 and its inhibitor IL-18BP in systemic lupus erythematosusPaola Migliorini, Consuelo Anzilotti, Federico Pratesi, et al.
Human Mutation|March 25, 2018
A homozygous variant disrupting the PIGH start-codon is associated with developmental delay, epilepsy, and microcephalyAlistair T Pagnamenta, Yoshiko Murakami, Consuelo Anzilotti, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Cellular & Molecular Immunology|June 20, 2017
Themis2: setting the threshold for B-cell selectionMukta Deobagkar-Lele, Consuelo Anzilotti, Richard J Cornall
Autoimmunity Reviews|June 23, 2009
Peptidylarginine deiminase 4 and citrullination in health and diseaseConsuelo Anzilotti, Federico Pratesi, Cristina Tommasi, et al.
Arthritis and Rheumatism|March 2, 2006
Deiminated Epstein-Barr virus nuclear antigen 1 is a target of anti-citrullinated protein antibodies in rheumatoid arthritisFederico Pratesi, Cristina Tommasi, Consuelo Anzilotti, et al.
Annals of the New York Academy of Sciences|July 15, 2005
A deiminated viral peptide to detect antibodies in rheumatoid arthritisGiuseppina Merlini, Consuelo Anzilotti, Daniele Chimenti, et al.
The Journal of Rheumatology|March 3, 2006
Antibodies to viral citrullinated peptide in rheumatoid arthritisConsuelo Anzilotti, Giuseppina Merlini, Federico Pratesi, et al.
Frontiers in Immunology|October 24, 2018
Immune Checkpoints as Therapeutic Targets in AutoimmunityChristopher Paluch, Ana Mafalda Santos, Consuelo Anzilotti, et al.
The Journal of Rheumatology|April 4, 2006
Prevalence and clinico-serological correlations of anti-alpha-enolase, anti-C1q, and anti-dsDNA antibodies in patients with systemic lupus erythematosusMarta Mosca, Daniele Chimenti, Federico Pratesi, et al.
Immunotherapy Advances|April 21, 2023
Combination CD200R/PD-1 blockade in a humanised mouse modelMartin Fellermeyer, Consuelo Anzilotti, Christopher Paluch, et al.
European Cytokine Network|December 4, 2010
Serum and urinary levels of IL-18 and its inhibitor IL-18BP in systemic lupus erythematosusPaola Migliorini, Consuelo Anzilotti, Federico Pratesi, et al.
Human Mutation|March 25, 2018
A homozygous variant disrupting the PIGH start-codon is associated with developmental delay, epilepsy, and microcephalyAlistair T Pagnamenta, Yoshiko Murakami, Consuelo Anzilotti, et al.
Pageof 3